A round of financing from 19 unnamed investors has pulled in almost $6 million for Nasoform. The Menlo Park, Calif.-based startup is working on a device to treat patients with collapsed nasal valves less invasively.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||